These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
969 related items for PubMed ID: 22733613
1. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases. Li X, Shen W, Cao J, Wang J, Chen F, Wang C, Zou S, Shen B, Zhao R, Li J, Shen Z. Ann Hematol; 2012 Nov; 91(11):1721-9. PubMed ID: 22733613 [Abstract] [Full Text] [Related]
2. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group. Li X, Liu Z, Cao J, Hong X, Wang J, Chen F, Wang C, Zou S, Li J, Shen Z. Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255 [Abstract] [Full Text] [Related]
3. The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma. Sohn BS, Kim SM, Yoon DH, Kim S, Lee DH, Kim JH, Lee SW, Huh J, Suh C. Ann Hematol; 2012 Nov; 91(11):1731-9. PubMed ID: 22752193 [Abstract] [Full Text] [Related]
4. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan. Tanaka T, Shimada K, Yamamoto K, Hirooka Y, Niwa Y, Sugiura I, Kitamura K, Kosugi H, Kinoshita T, Goto H, Nakamura S. Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617 [Abstract] [Full Text] [Related]
5. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma. Stefancikova L, Moulis M, Fabian P, Vasova I, Zedek F, Ravcukova B, Muzik J, Kuglik P, Vranova V, Falkova I, Hrabalkova R, Smardova J. Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232 [Abstract] [Full Text] [Related]
6. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK, Lymphoma Study Division of the Korean Cancer Study Group. Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337 [Abstract] [Full Text] [Related]
7. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, Bar-Shalom R. Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884 [Abstract] [Full Text] [Related]
15. Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era. Lu HJ, Huang YC, Liu CY, Hung MH, Hu MH, Wu CY, Hong YC, Hsiao LT, Gau JP, Liu JH, Hsu HC, Chiou TJ, Tzeng CH, Yu YB. Ann Hematol; 2013 Nov; 92(11):1495-501. PubMed ID: 23712292 [Abstract] [Full Text] [Related]